Hypertrophy: Clinical Trials

7 trials for Hypertrophy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown. 7 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 37Unknown 7
Phase 23Unknown 3

Follow Hypertrophy: new trials by email Literature Review of Hypertrophy trials Research Report on Hypertrophy

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Dapagliflozin on Myocardial and Renal Function Following Aortic Valve Stenosis Intervention
SGLT2 inhibitor, Placebo - Aortic Stenosis, Left Ventricle Hypertrophied
Phase 2 / Phase 3UnknownUniversity of Aarhus1062022-02-122022-02-15
Systemic Hormones and Muscle Protein Synthesis
Sustanon 250, Zoladex, Placebo - Sarcopenia, Muscle Hypotrophy
Phase 3UnknownUniversity of Nottingham342016-12-152019-02-26
Myocardial Protection With Perhexiline in Left Ventricular Hypertrophy
Perhexiline, Placebo marked PEXSIG - Myocardial Reperfusion Injury, Cardiac Output, Low
Phase 2 / Phase 3UnknownUniversity Hospital Birmingham2202009-10-012011-08-11
Effects of High Dose Atorvastatin in Patients With Surgical Aortic Stenosis
Atorvastatin 80 mg - Aortic Valve Stenosis, Ventricular Hypertrophy
Phase 3UnknownUniversity Hospital, Strasbourg, France602008-12-012015-06-19
Open-Label Extension of LOCKCYST Trial
lanreotide - Polycystic Liver Disease, Hepatomegaly
Phase 2 / Phase 3UnknownRadboud University Medical Center542008-04-012008-11-13
Stenting of Renal Artery Stenosis in Coronary Artery Disease Study
stenting angioplasty plus medical therapy, Medical therapy - Renal Artery Stenosis, Left Ventricular Hypertrophy
Phase 3UnknownAzienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele1682006-04-012010-08-02
Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis
Candesartan - Aortic Valve Stenosis, Left Ventricular Hypertrophy
Phase 3UnknownOdense University Hospital1402006-02-012009-06-30

Narrower conditions

Hypertrophy, Left Ventricular (5)  ·  Aortic Valve Stenosis (4)  ·  Atrial Fibrillation (1)  ·  Cardiac Output, Low (1)  ·  Hepatomegaly (1)  ·  Liver Diseases (1)  ·  Multiple Pterygium Syndrome, Autosomal Dominant (1)  ·  Muscular Atrophy (1)  ·  Myocardial Reperfusion Injury (1)  ·  Polycystic Kidney Diseases (1)  ·  Polycystic liver disease (1)  ·  Renal Artery Obstruction (1)  ·  Sarcopenia (1)

Broader conditions

Pathological Conditions, Anatomical (7)  ·  Pathological Conditions, Signs and Symptoms (7)  ·  Cardiomegaly (5)  ·  Cardiovascular Diseases (5)  ·  Heart Diseases (5)  ·  Aortic Valve Disease (4)  ·  Heart Valve Diseases (4)  ·  Ventricular Outflow Obstruction (4)  ·  Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Kidney Diseases (2)  ·  Male Urogenital Diseases (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)

Interventions

Atorvastatin (1)  ·  Gonadotropin-Releasing Hormone (1)  ·  Goserelin (1)  ·  Nutrition Therapy (1)  ·  Perhexiline (1)  ·  Sodium Chloride (1)  ·  Sodium-Glucose Transporter 2 Inhibitors (1)  ·  Testosterone (1)  ·  candesartan (1)  ·  lanreotide (1)

Sponsors

Azienda Ospedaliera, Universitaria Policlinico Vittorio Emanuele (1)  ·  Odense University Hospital (1)  ·  Radboud University Medical Center (1)  ·  University Hospital Birmingham (1)  ·  University Hospital, Strasbourg, France (1)  ·  University of Aarhus (1)  ·  University of Nottingham (1)

Countries

Denmark (2)  ·  United Kingdom (2)  ·  Belgium (1)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Carmelita Marcantoni, M.D. (1)  ·  Domeinco Pagano, MD FRCS (1)  ·  Frederik Nevens, MD, PhD (1)  ·  Henrik Nissen, MD, PhD (1)  ·  Jacob E Moller, Md, Ph.D (1)  ·  Joost PH Drenth, PhD (1)  ·  Jordi S Dahl, MD, MMSci (1)  ·  Lars I Andersen, MD, DMSc (1)  ·  Loes van Keimpema, MSc (1)  ·  Nathaniel Szewczyk, Ass. Proff (1)  ·  Philip J Atherton, Professor (1)  ·  Steen Hvitfeldt Poulsen (1)  ·  Torben Haghfelt, Md, DMSc (1)

Results publications

PMID 21353251, PMID 22495466, PMID 22869821, PMID 23316326, PMID 24173271, PMID 27085434, PMID 35224730, PMID 40665514